GlassScriptPhysician profile
Puneet Chopra
NPI 1508200668
$1,877.29
in general payments reported to CMS, 2019-2025
30 companies · $71.31 in 2025
The $71.31 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $72.77 · 2021: $281 · 2022: $543 · 2023: $289 · 2024: $108 · 2025: $71.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $393.03 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $197.41 | 2019-2023 | |
| Abbvie INC. | $140.36 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $112.81 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $107.47 | 2019-2022 | |
| Vivus LLC | $89.76 | 2024 | Qsymia |
| Novo Nordisk INC | $87.44 | 2019-2023 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $82.21 | 2019-2023 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.53 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.80 | 2021-2023 | |
| Mylan Specialty L.P. | $60.19 | 2021-2023 | Yupelri |
| Abbott Laboratories | $51.80 | 2022-2025 | Freestyle Libre 3 |
| Ceribell, INC. | $48.10 | 2025 | Pocket Eeg Device |
| Dexcom, INC. | $38.91 | 2022-2023 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $35.88 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $35.63 | 2022 | |
| Glaxosmithkline, LLC. | $32.35 | 2021-2023 | Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $25.87 | 2022 | |
| Exact Sciences Corporation | $19.72 | 2023 | Cologuard Collection Kit |
| Radius Health, INC. | $19.57 | 2019 | |
| Astellas Pharma US INC | $18.83 | 2022 | |
| Amarin Pharma, INC. | $18.17 | 2021 | |
| Jazz Pharmaceuticals INC. | $17.78 | 2022 | |
| Insmed, INC. | $17.15 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.90 | 2021 | |
| Horizon Therapeutics Plc | $13.21 | 2021 | |
| Lilly USA, LLC | $12.61 | 2019 | |
| Grt US Holding, INC. | $11.53 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puneet Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.